Trelegy denied due to quantity / dose limits by Cigna?

Cigna's specific coverage criteria for trelegy are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Imposes Quantity Limits on Trelegy

Trelegy Ellipta is a once-daily inhaled triple combination used for COPD or asthma maintenance. Cigna, like most insurers, applies quantity limits (QL) to branded inhalers — typically capping the number of inhalers dispensed per fill or per defined period. A quantity-limit denial means the prescription as written exceeds that cap. This may reflect a legitimate clinical need (e.g., a physician prescribed extra units for travel backup) or a simple supply-day mismatch between the prescription and the plan's allowed quantity.

## Why a Quantity-Limit Denial Is Appealable

Quantity limits are not absolute. Plans must allow exceptions when clinical evidence demonstrates that the standard quantity is insufficient for your medical needs. If your physician can document a clinical reason — such as severe disease requiring closer titration monitoring, documented inhalation technique concerns requiring more frequent device replacement, or travel requirements — a quantity-limit exception is appropriate grounds for appeal.

## Your Federal Appeal Rights

• Internal appeal: File a formal appeal with your clinical justification within the timeframe shown on your EOB. Cigna must respond within the applicable regulatory deadline.
• External review (ACA §2719): A quantity-limit denial is a coverage decision subject to independent external review once the internal process is exhausted — typically within about four months of the original denial.
• ERISA §503: Employer-plan members may request a full-and-fair review and obtain all documents used in the quantity-limit determination.
• Expedited review: If the quantity restriction leaves you without medication imminently, request expedited review for a faster decision.

## Documentation to Gather

• Prescription as written: The exact quantity prescribed and the prescriber's intended supply period.
• Clinical justification letter: Your physician should explain specifically why the requested quantity is medically necessary — for example, device malfunction history, adherence support, travel, or clinical severity.
• Diagnosis and severity records: Chart notes documenting the underlying condition and why uninterrupted access to Trelegy is critical.
• Cigna's quantity-limit policy: Request the exact quantity limit applied; you are entitled to this under ERISA or state law.
• Pharmacy records: Prior dispense history showing your usage pattern.

## Criteria-Mapping Structure

Identify the exact quantity Cigna allows versus what was prescribed. Then build your appeal around the gap:

| Plan's Quantity Limit | Prescribed Quantity | Clinical Reason for Difference | |---|---|---| | [Cigna's limit per policy] | [Physician's prescribed amount] | [Physician's documented rationale] |

Attach the prescriber's letter as the primary exhibit, supported by relevant chart notes. A brief, specific clinical narrative from the prescriber — rather than a generic medical-necessity form — consistently produces better appeal outcomes for quantity-limit cases.